BR112012033657A2 - dispositivos oftálmicos que contêm antagonistas de quimioquina - Google Patents

dispositivos oftálmicos que contêm antagonistas de quimioquina

Info

Publication number
BR112012033657A2
BR112012033657A2 BR112012033657A BR112012033657A BR112012033657A2 BR 112012033657 A2 BR112012033657 A2 BR 112012033657A2 BR 112012033657 A BR112012033657 A BR 112012033657A BR 112012033657 A BR112012033657 A BR 112012033657A BR 112012033657 A2 BR112012033657 A2 BR 112012033657A2
Authority
BR
Brazil
Prior art keywords
ophthalmic devices
devices containing
chemokine antagonists
containing chemokine
methods
Prior art date
Application number
BR112012033657A
Other languages
English (en)
Inventor
Dijana Draganovic
Hassan Chaouk
Vandeeta Khanolkar
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of BR112012033657A2 publication Critical patent/BR112012033657A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Eyeglasses (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

dispositivos oftálmicos que contêm antagonistas de quimioquina. a presente invenção refere-se a dispositivos oftálmicos iônicos, a métodos para tratar condições inflamatórias mediadas pelo receptor de citocina quimiotática 2 (ccr2), e a métodos para fabricar tais dispositivos.
BR112012033657A 2010-06-30 2011-06-29 dispositivos oftálmicos que contêm antagonistas de quimioquina BR112012033657A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35996310P 2010-06-30 2010-06-30
PCT/US2011/042404 WO2012012184A2 (en) 2010-06-30 2011-06-29 Ophthalmic devices containing chemokine antagonists

Publications (1)

Publication Number Publication Date
BR112012033657A2 true BR112012033657A2 (pt) 2016-11-29

Family

ID=44501773

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012033657A BR112012033657A2 (pt) 2010-06-30 2011-06-29 dispositivos oftálmicos que contêm antagonistas de quimioquina

Country Status (13)

Country Link
US (1) US20120004298A1 (pt)
EP (1) EP2588049A2 (pt)
JP (1) JP2013536457A (pt)
KR (1) KR20130083900A (pt)
CN (1) CN102958508A (pt)
AR (1) AR084703A1 (pt)
AU (1) AU2011279992A1 (pt)
BR (1) BR112012033657A2 (pt)
CA (1) CA2803368A1 (pt)
RU (1) RU2013103784A (pt)
SG (1) SG186474A1 (pt)
TW (1) TW201206424A (pt)
WO (1) WO2012012184A2 (pt)

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL285986A (pt) 1961-12-27
NL128305C (pt) 1963-09-11
US4113224A (en) 1975-04-08 1978-09-12 Bausch & Lomb Incorporated Apparatus for forming optical lenses
US4197266A (en) 1974-05-06 1980-04-08 Bausch & Lomb Incorporated Method for forming optical lenses
US4495313A (en) 1981-04-30 1985-01-22 Mia Lens Production A/S Preparation of hydrogel for soft contact lens with water displaceable boric acid ester
US4680336A (en) 1984-11-21 1987-07-14 Vistakon, Inc. Method of forming shaped hydrogel articles
US4691820A (en) 1985-11-18 1987-09-08 Vistakon, Inc. Package for hydrophilic contact lens
US4889664A (en) 1988-11-25 1989-12-26 Vistakon, Inc. Method of forming shaped hydrogel articles including contact lenses
NZ250453A (en) 1992-12-21 1996-12-20 Johnson & Johnson Vision Prod Ophthalmic lens package; planar surface with concave bowl for containing lens, sealing sheet covering bowl with lens therein
US5823327A (en) 1993-11-02 1998-10-20 Johnson & Johnson Vision Products, Inc. Packaging arrangement for contact lenses
US5696686A (en) 1994-06-10 1997-12-09 Johnson & Johnson Vision Products, Inc. Computer system for quality control correlations
US5488815A (en) 1994-06-10 1996-02-06 Johnson & Johnson Vision Products, Inc. Apparatus and method for sterilization and secondary packaging
US5577367A (en) 1994-06-10 1996-11-26 Johnson & Johnson Vision Products, Inc. Apparatus and method for sterilization and secondary packaging
US5704468A (en) 1995-09-29 1998-01-06 Johnson & Johnson Vision Products, Inc. Packaging arrangement for contact lenses
US6277365B1 (en) * 1997-09-18 2001-08-21 Bausch & Lomb Incorporated Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
US6822016B2 (en) 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US6018931A (en) 1998-09-08 2000-02-01 Johnson & Johnson Vision Products, Inc. Method and support for supporting packages only at their edges during steam sterilization
US6050398A (en) 1998-11-25 2000-04-18 Novartis, Ag Contact lens storage container
USD435966S1 (en) 1999-01-29 2001-01-09 Johnson & Johnson Vision Care, Inc. Contact lens container
US20040091613A1 (en) * 2002-11-13 2004-05-13 Wood Joe M. Methods for the extraction of contact lenses
JP4379778B2 (ja) * 2003-04-03 2009-12-09 株式会社シード 薬物徐放性眼用レンズ
AU2005267385B2 (en) * 2004-06-25 2011-11-10 Janssen Pharmaceutica N.V. Quaternary salt CCR2 antagonists
EP2142219A2 (en) * 2007-03-30 2010-01-13 Johnson & Johnson Vision Care, Inc. Preparation of antimicrobial contact lenses with reduced haze using swelling agents
US10105441B2 (en) * 2007-08-16 2018-10-23 The Schepens Eye Research Institute, Inc. Method for inhibiting or reducing dry eye disease by IL-1Ra
AU2009204441B2 (en) * 2008-01-09 2015-03-05 The Schepens Eye Research Institute, Inc. Therapeutic compositions for treatment of ocular inflammatory disorders
US8470906B2 (en) 2008-09-30 2013-06-25 Johnson & Johnson Vision Care, Inc. Ionic silicone hydrogels having improved hydrolytic stability

Also Published As

Publication number Publication date
JP2013536457A (ja) 2013-09-19
RU2013103784A (ru) 2014-08-10
US20120004298A1 (en) 2012-01-05
AU2011279992A1 (en) 2013-01-10
SG186474A1 (en) 2013-02-28
CN102958508A (zh) 2013-03-06
TW201206424A (en) 2012-02-16
WO2012012184A3 (en) 2012-11-15
CA2803368A1 (en) 2012-01-26
WO2012012184A2 (en) 2012-01-26
KR20130083900A (ko) 2013-07-23
EP2588049A2 (en) 2013-05-08
AR084703A1 (es) 2013-06-05

Similar Documents

Publication Publication Date Title
UY4276Q (es) Controlador para dispositivo electrónico
CL2016000221A1 (es) Anticuerpos anti-fgfr2iiib afucosilados.
EA201591137A1 (ru) Ингибиторы mk2 и их применения
UY4275Q (es) Controlador para dispositivo electrónico
UY34559A (es) Inhibidores de bromodominios
UY34832A (es) TIAZOLES SUSTITUIDOS POR CARBOXAMIDA O SULFONAMIDA Y DERIVADOS RELACIONADOS COMO MODULADORES PARA EL RECEPTOR NUCLEAR HUÉRFANO RORy (lambda)
UY34817A (es) Tienopirimidinas
CR20120298A (es) Antagonistas de il-17a
UY34824A (es) Nucleósidos de espirooxetano de uracilo
UY34515A (es) Triazolopiridinas sustituidas
UY34666A (es) Inhibidores de quinasa a base de ariléter
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
UY34767A (es) Inhibidores cíclicos del enlace éter de dgat1
UY34730A (es) Formulaciones farmacéuticas que comprenden antagonistas de ccr3
EA032920B1 (ru) Способы получения соединений бензохинолина
UY34863A (es) Antagonistas de iap
UY33856A (es) ?gen y variaciones asociadas con el fenotipo bm1, marcadores moleculares y su uso?.
UY34590A (es) Fenilimidazopirazoles sustituidos y su uso
MA37989A1 (fr) Amines cycliques
UY34677A (es) Imidazopiridazinas sustituidas
BR112012033657A2 (pt) dispositivos oftálmicos que contêm antagonistas de quimioquina
WO2015066189A3 (en) Modification of nuclear actin by mical-2 regulates srf signaling
UA116372C2 (uk) Частинки резинату фенілефрину
BR112015016741A2 (pt) composição, dispositivo e sistema
ES2571439T3 (es) Cepa de Glomus iranicum var. tenuihypharum var. nov. y su uso como bionematicida

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]